Clinical Trial Update: Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes

View source ↗

Summary

A completed Indian clinical trial investigates whether combining gene variants can improve risk prediction for metabolic dysfunction-associated fatty liver dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Metabolic Dysfunction-associated Fatty Liver Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Medanta, The Medicity, India | Conditions: Type2diabetes | Status: COMPLETED